Furthermore, a recent study reported higher serum levels of inflammatory and anti-inflammatory biomarkers, as well as the growth factors fibroblast growth factor-2 (FGF-2), platelet-derived growth factor (PDGF), and VEGF, in an MPS group compared with a non-MPS control group (Grosman-Rimon et al., 2016). The gene discussed is VEGFA; the disease is mucopolysaccharidosis.